In our lates video produced by Innovation Zurich , MUVON's CEO, Deana Mohr, shares, among other things, how the Zurich-based spin-off...

Longevity.Technology  recently published an interview with MUVON CEO, Deana Mohr, focusing on our mission to redefine health and...

MUVON CEO, Deana Mohr-Haralampieva, was recently featured in an exclusive interview with PharmaBoardroom

We are delighted to announce that our latest paper has been published in Nature Reviews Bioengineering: Down to Business. The paper dives...

MUVON ranked as a top 3 Biotech and overall 18th in 2024s TOP 100 Swiss Startups ranking

Discover how MUVON is transforming bladder incontinence treatment with a pioneering approach in tissue engineering in our latest interview by founded.ch . Our CEO, Deana Mohr explains how our innovative startup uses patients' own cells to regenerate pelvic muscles. This therapy has the potential to be a safer and more effective solution compared to traditional methods, offering hope to millions affected by this condition. Read the full article here to learn more about MUVON'

MUVON Therapeutics was featured by Nature as one of the companies leading the way with innovative treatments for stress urinary incontinence, showcasing the immense potential in women's health advancements. Despite women driving 80% of healthcare spending, women's health receives less than 1% of biopharma funding. Deana Mohr, CEO of MUVON Therapeutics, highlights the issue: "Investors often see women’s health as a niche 'wellness' sector rather than an area of high unmet medi

With our novel therapy platform for skeletal muscle regeneration, the MUVON team has won the prize of 10k as a runner up for the ZKB Pionierpreis 2023. The Pionierpreis or "pioneer award" is considered the leading innovation award for deep-tech start-ups in Switzerland and a significant achievement for young companies. The Pioneer Award honors projects at the transition from an innovative idea to marketability. At this point, start-ups are still usually a long way from maki

MUVONs CEO Deana Mohr had the great honor to present MUVONs technology and visions to Prof. Shinya Yamanaka before his public lecture at the University of Zurich on Friday, 16.09.2022. Founder and Director Emeritus of the Center for iPS Cell Research and Applications at Kyoto University (Japan), Prof. Yamanaka can be called the godfather of iPSCs. MUVON Therapeutics and Prof. Yamanaka share the goal to bring personalized medicine solutions to patients in need. During his lec

MUVON Therapeutics was selected by the Lichtsteiner Foundation to become a part of their supported community of pioneering innovators. For the Lichtsteiner Foundation Testimonial video series showcasing their community, CEO and co-founder Deana Mohr spoke about MUVON Therapeutics' mission to establish personalised treatments for the regeneration of skeletal muscle as primary standard of care. You can find the video under the following link: Community | Lichtsteiner Foundatio

Our CEO Deana Mohr had the great opportunity to present MUVONs vision and innovative regenerative cell therapy in an interview for BioInnovation Spotlight @ LifeScience ORG! Listen to the interview here: https://bioinnovation.captivate.fm/episode/13-deana-mohr or on Spotify: https://open.spotify.com/episode/3fjHsK0ZfIWHS1rawOj2Fd?si=aoZ_SZ0bSseTtnWF5jr2Sg

MUVON Therapeutics CEO Deana Mohr was selected as one of ten Venture Leaders in Medtech to represent the Swiss National Startup Team in the USA this October. The Venture Leaders Medtech roadshow will introduce Switzerland’s most innovative mobile startups to international investors and industry leaders at the global hub of life sciences in the Greater Boston Area. Venture Leaders Medtech 2021 is organized by Venturelab and supported by EPFL (École polytechnique fédérale d

MUVON was featured in an article by Startupticker describing our regenerative approach for the treatment of incontinence and the progress our fantastic team has made so far! Read the article here .

The University of Zurich (UZH) is advancing biotechnology with innovations. Thanks to a systematic support system and the dynamic...